Ciprofloxacin for infection prevention in patients with acute leukemia
- 1 February 1987
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 9 (1) , S45-S47
- https://doi.org/10.1007/bf02075259
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patientsThe American Journal of Medicine, 1986
- Ciprofloxacin for Selective Decontamination of the Alimentary Tract in Patients with Acute Leukemia During Remission Induction Treatment: The Effect on Fecal FloraThe Journal of Infectious Diseases, 1985
- Editorial BoardCancer Letters, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Selective Antimicrobial Modulation as Propbylaxis Against Infection During Granulocytopenia: Trimetboprim-Sulfametboxazole vs. Nalidixic AcidThe Journal of Infectious Diseases, 1983
- Prevention of Infection by Trimethoprim-Sulfamethoxazole Plus Amphotericin B in Patients with Acute Nonlymphocytic LeukaemiaAnnals of Internal Medicine, 1981
- Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractPublished by Elsevier ,1980
- Origin of Infection in Acute Nonlymphocytic LeukemiaAnnals of Internal Medicine, 1972